| Factor Information | |
|---|---|
| Data ID | 2882 |
| Factor | Transcutaneous oxygen saturation |
| Description | Transcutaneous oxygen saturation of all patients underwent radical repair selected by Diagnostic-treatment-and-repair strategy increased significantly from pre-Diagnostic-treatment 87.5±8.2 to post-Diagnostic-treatment 95.8±5.6 (P<0.001). |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | This study aimed to examine the nature of the pulmonary arterial vessels in these selective patients. |
| p Value | <0.001 |
| Conclusion | Transcutaneous oxygen saturation of all patients underwent radical repair selected by Diagnostic-treatment-and-repair strategy increased significantly from pre-Diagnostic-treatment 87.5±8.2 to post-Diagnostic-treatment 95.8±5.6 (P<0.001). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 635 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD, VSD/VSD/ASD/TGA, VSD/TBA |
| Reference | |
|---|---|
| PMID | 20494465 |
| Year | 2011 |
| Title | Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | Lung biopsy specimens | |
| Region | Beijing, China | |
| Method | All specimens were quantitatively analyzed | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | radical repair | |
| Group | Pre SpO2 (transcutaneous oxygen saturation of pretreatment)(Treatment) | Drug SpO2(transcutaneous oxygen saturation after drug treatment)(Control) |
| Number | 49 | 49 |
| Age | 36.5±23.8 months | 36.5±23.8 months |
| Gender (Male: Female) | 29:20 | 29:20 |
| Marker Level | 87.5±8.2% | 95.8±5.6% |
